Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
The investment case for health technology in India is frequently overstated in one direction and understated in another
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Former Wavemaker executive to lead media strategy and digital transformation agenda
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
Subscribe To Our Newsletter & Stay Updated